Co-Authors
This is a "connection" page, showing publications co-authored by SANKAR NAVANEETHAN and BIYKEM BOZKURT.
Connection Strength
0.295
-
Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD. Clin J Am Soc Nephrol. 2025 Dec 01.
Score: 0.244
-
Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
Score: 0.051